Clinical Trials For Heel Pain (Plantar Fasciitis)

[Guest guest]

Clinical Trials For Heel Pain (Plantar Fasciitis)

http://www.medicalnewstoday.com/medicalnews.php?newsid=39644

BioElectronics Corporation, (Pink Sheets: BIEL), announced today it

has commenced a series of double-blind clinical trials to be

conducted in conjunction with leading schools of podiatry and

selected clinics to document the effects of ActiPatch on treating

plantar fasciitis [heel pain].

The studies are starting this month with early results expected

within 90 days. The Principal Investigator for the study is Dr.

Van der Reis, a Board Certified Orthopedic Surgeon and sports

medicine specialist. The study protocol was approved by the

Investigational Review Board, Coast IRB, of San Clemente, CA.

The Company anticipates submission of the trial results to the FDA to

obtain additional regulatory clearances. " This series of clinical

trials are essential to establish broader regulatory and market

approval for our expanded line of innovative drug-free, anti-

inflammatory products, said O'Connor, Chief Operating

Officer. " We are grateful to our clinical partners and to our Medical

Advisory Board for all the efforts they have put forth in getting

these important research projects moving forward. "

ActiPatch is a drug-free anti-inflammatory patch with an embedded

battery operated microchip that delivers weeks of continuous pulsed

therapy for less than a dollar a day. The unique ActiPatch delivery

system, using patented technology, provides a cost-effective, patient

friendly method to reduce soft tissue pain and swelling.

For more information visit http://www.bioelectronicscorp.com